We tested the hypothesis that inhibition of Notch signaling increases the sensitivity of FLT3/ITD + AML cells to TKIs, although the exact mechanisms that lead to the activation of Notch signaling upon TKI treatment require further investigation. This evidence concerns the gene FLT3 and acute myeloid leukemia.